Work

Cetuximab and chemotherapy in the treatment of patients with initially “nonresectable” colorectal (CRC) liver metastases: Long-term follow-up of the CELIM trial.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.3538

Authors: Gunnar Folprecht, Thomas Gruenberger, Wolf Bechstein, Hans-Rudolf Raab, Juergen Weitz, Florian Lordick, Joerg Thomas Hartmann, Hauke Lang, Tanja Trarbach, Jan Stoehlmacher-Williams, Torsten Liersch, Detlev Ockert, Dirk Jaeger, Ulrich Steger, Thomas Suedhoff, Claus-Henning Kohne

Institutions: University Hospital Carl Gustav Carus, Medical University of Vienna, University Hospital Frankfurt, Klinikum Oldenburg, University Hospital Leipzig, University Hospital Schleswig-Holstein, University Medical Center of the Johannes Gutenberg University Mainz, University of Duisburg-Essen, Universitätsmedizin Göttingen, University of Göttingen, Krankenhaus der Barmherzigen Brüder Trier, Heidelberg University, National Center for Tumor Diseases, University of Würzburg, Universitätsklinikum Würzburg, Klinikum Passau

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2597833733

Cites:

Cited by: 6

Related to: 10